Voices: PharmaView

PharmaView: Single-Use Standards: What’s the Rush?

Can standardization and innovation coexist?

By Paul Thomas, Senior Editor

Increasingly in our industry, “subject matter experts” are found within the vendor community. Many of pharma’s best and brightest have retired or been laid off, while other SME’s enjoy developing technological advances (rather than waiting, in the end user community, for them to appear). One area where vendors hold a monopoly on SME’s is in single-use technologies.

Read more

More from this voice...


PharmaView: The Future? Let's Get Pumped Up

To survive, Steven Burrill tells Big Pharma, ignore the “gravel in the road” and embrace the disruption.


PharmaView: Carrots, Sticks, and CEOs

Salary does not dictate motivation and performance.


PharmaView: Who Will Be Pharma's Kane Waselenchuk?

As conventional ways of making drugs give way, we will seek out these people and value their brilliance.


PharmaView: Time Away from a Life in Big Pharma

“It is worth having dreams,” and worth fulfilling them, says former Novartis employee Anna Kroczak.


PharmaView: Coming to America: European Companies Buy In and Lease

"OUS" companies are enjoying the U.S. market, and creating a few jobs along the way.


PharmaView: Can Manufacturing Be Sexy for Millennials?

If not, maybe greed can help overcome manufacturing’s PR problem with young professionals.


PharmaView: Fake Drugs: Why Business is Booming

It’s time to make counterfeiting less economically tantalizing.


PharmaView: Are Unions (Love 'Em or Not) the Last Bastion for Pharma Job Security?

Communities can partner with manufacturers, but they can’t apply pressure.


PharmaView: Sell No Harm

Makers of drugs for lethal injection face pressure to spurn U.S. prisons.


PharmaView: Shattered Trust in Manufacturing and FDA, a Renewed Faith in the Press

A Milwaukee newspaper reminds an industry of its flaws.


PharmaView: Can RFID Make Waves Again?

Reports of the demise of radio frequency identification as a breakthrough supply chain technology have been greatly exaggerated.


PharmaView: What's the Prescription for Painkiller Nation?

With FDA and the Obama administration on alert, it is drug manufacturers' turn to address a crisis.


PharmaView: What’s Your Saving Story?

There’s nothing like a good tale of frugality to make your day.


PharmaView: Should Pharma Fear the Supply Chain of the Future?

As paradigms shift, we also need paradigm expansion.


PharmaView: Pharma Job Cuts: Decisive, Long-term Strategic Actions?

There’s no good way to deliver bad news, but that doesn’t mean it should be hidden or glossed over.


PharmaView: CEOs: Head Cases?

For CEOs, maybe therapy comes with the territory.


PharmaView: Pharma M&As: Been There, Done That?

If the “serial acquirers” don’t kill us, they’ll make us stronger.


PharmaView: Our Employability Challenge

It may be hard to find good help, but it’s also hard to find good work.


PharmaView: Where Everybody Knows Your Name

If Ashton Kutcher were in pharma, he’d be on LinkedIn.


PharmaView: What's In Your Wastewater? It's Time to Find Out

We have little grasp of the downstream impact of API's being discharged from our facilities.